The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice
- Lookup NU author(s)
- Huw Thomas
- Suzanne Kyle
- Ivanda Pavlovska
- Professor Nicola Curtin
|
|
|
|
| Author(s) | | Ali M, Kamjoo M, Thomas HD, Kyle S, Pavlovska I, Babur M, Telfer BA, Curtin NJ, Williams KJ |
| Publication type | | Article |
| Journal | | Molecular Cancer Therapeutics |
| Year | | 2011 |
| Volume | | 10 |
| Issue | | 12 |
| Pages | | 2320-2329 |
| ISSN (print) | | 1535-7163 |
| ISSN (electronic) | | 1538-8514 |
|
|
|
| Full text for this publication is not currently held within this repository. Alternative links are provided below where available. |
|
|
|
| Publisher | | American Association for Cancer Research |
| URL | | http://dx.doi.org/10.1158/1535-7163.MCT-11-0356 |
| DOI | | 10.1158/1535-7163.MCT-11-0356 |
|
|
Actions | |   |
